Clinical trial Recruiting at 1 site Observational Ages 18 and up

Integrated, nurse-led digital remote monitoring for cardiovascular risk management

Official title: Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT07208331 · Data updated 2026-11-12

This observational program tests a nurse-led, at-home telemonitoring care pathway to help adults with ASCVD, hypertension, or dyslipidemia better manage blood pressure and cholesterol.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment750 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedMarch 30, 2026
Main results expectedMarch 30, 2028
Study endsMarch 30, 2030
Registry record updatedOctober 9, 2026
Trial IDNCT07208331 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older enrolled in the digital program, including high- and very high-risk patients with ASCVD, hypertension, or dyslipidemia.

Probably not a fit

Patients without access to smartphones/tablets or those unable to use digital tools may derive limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study observes how a digital, nurse-led remote monitoring pathway works when used in routine care for people at risk of or with established cardiovascular disease. Participants track blood pressure and LDL-C at home, complete surveys on quality of life, medication adherence, system usability, and satisfaction, and receive personalized care guided by telemonitoring data. The goal is to see if this approach improves risk stratification, early intervention, and control of lipids and blood pressure compared with standard follow-up. It is designed as an implementation evaluation across cardiology centers in the Netherlands, using data from everyday clinical practice. No experimental treatments are administered beyond the digital care pathway itself.

Why it matters

Potential benefit: If successful, the pathway could improve adherence and improve blood pressure and lipid control, potentially reducing cardiovascular risk.

How similar studies have gone: Previous telemonitoring and nurse-led care programs have shown promise in improving cardiovascular risk management in various settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* All patients enrolled in the program (high-risk and very high-risk patients)

Exclusion Criteria:

* Not able to provide informed consent
* No access to smartphone and/or tablet
* Inability to use digital tools required for the program

Where it's running

  • Cardiology Centers of the Netherlands (CCN)
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.